Ayami Kaneko, Nobuaki Kobayashi, Kenji Miura, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, et al. Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thoracic cancer. 2024
Momo Hirata, Yu Hara, Hiroaki Fujii, Kota Murohashi, Yusuke Saigusa, Shiqi Zhao, Miyu Kobayashi, Ryo Nagasawa, Yoichi Tagami, Ami Izawa, et al. ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases. BMC pulmonary medicine. 2024. 24. 1. 16-16
Yoichi Tagami, Yu Hara, Kota Murohashi, Ryo Nagasawa, Hiroaki Fujii, Ami Izawa, Aya Yabe, Yusuke Saigusa, Miyu Kobayashi, Masafumi Shiida, et al. Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease. Scientific reports. 2023. 13. 1. 22639-22639
Yoichi Tagami, Nobuyuki Horita, Megumi Kaneko, Suguru Muraoka, Nobuhiko Fukuda, Ami Izawa, Ayami Kaneko, Kohei Somekawa, Chisato Kamimaki, Hiromi Matsumoto, et al. Whole-genome sequencing predicting phenotypic antitubercular drug resistance: meta-analysis. The Journal of infectious diseases. 2023
Nobuaki Kobayashi, Kenji Miura, Ayami Kaneko, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, et al. Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers. 2023. 15. 21